Clinical Trials

Clinical trials are the foundation of everything we hope to achieve. 
 

Getting approval is a journey. We need to test a diverse group of patients order to deliver our life-changing therapies for the broadest range of patients.

 

 

Nanodose Therapeutics will be conducting clinical studies in 2026 of NanoSLO most likely in Australia and then subsequently in the United States. 

​

For now, please click on the logo below to learn more about ongoing trials for TBI